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Abstract
Ischaemic pain belongs amongst the most difficult to treat pains in palliative care. The pain is frequently
severe and resistant to available analgesics. Treatment of this condition is difficult especially when the
condition is inoperable. We describe a patient with severe ischaemic pain in the lower leg due to previous
vascular problems and superimposed deep venous thrombosis who responded well to action potential
simulation (APS), a therapy using microcurrents which resemble the body’s own biocurrents. This technol-
ogy is frequently used by complementary therapists but is still barely known to evidence-based medicine.
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Introduction
Ischemic pain belongs to the most recalcitrant
symptoms in Palliative Care. Fortunately, this type
of pain is rare among patients suffering of cancer,
but its prevalence is dramatically higher in patients
suffering of diabetes and vascular diseases [1, 2].
As a rule ischemic limb pain is severe, highly vari-
able during the day and is accompanied by pale-
ness and a cold feeling in the distal part of extrem-
ity. Treatment of this condition is primarily by surgi-
cal procedure: a bypass or arterial prosthesis/stent
[3, 4]. When this is impossible or contraindicated
some improvement can be expected from sympath-
ectomy [5, 6], nerve section [7] or epidural mor-
phine [8] but the evidence for this is weak. Ischemic
pain responds poorly to analgesics and this is the
reason why different techniques are often tried [9,
1]. In this article we describe a patient with severe
ischemic pain in lower leg who responded well to
action potential simulation (APS), therapy with mi-
cro-currents that resembles body own biocurrents.
This technology is frequently used by complemen-
tary therapists, but still hardly known to the evi-
dence based medicine [11, 12].
Case report
Mr. K (65) was urgently referred to the pain
clinic because of the severe pain in his left lower
leg. He had a history of arterial insufficiency and
prosthesis in the left popliteal artery and in the
past he was using warfarin. However, when he
developed oesophageal cancer and became anaem-
ic warfarin was discontinued. Two months later he
developed left sided deep vein thrombosis. This
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was accompanied by a severe pain in the left leg.
Doppler ultrasound investigation confirmed throm-
bosis in the femoral vein, but also showed no blood
circulation beyond the popliteal artery. Fraxiparin
was commenced but discontinued because of small
brain bleeding confirmed by the brain CT scan. The
pain was present during and after therapy with
Fraxiparine. At assessment the pain was much
worse on movement and the action radius was not
more than several meters. He slept poorly, usually
sitting in the chair. He used oral morphine (mor-
phine sulphate tablets with controlled release, 100
mg a day and oral morphine sulphate of immedi-
ate release several times a day, 15 mg per dose).
Unfortunately this medication was not able to in-
fluence his pain. He and his surrounding noticed
his mental deterioration, depression, sometimes
agitation. On examination: multiple venectasies.
The left lower leg was swollen and cold around the
knee. Palpation was not painful. There were no
arterial pulsations palpable starting from the iliac
artery in the groin. No bruits. Pulsations on the
right leg were normal. On the shin, on the heel and
on the second toe of the left leg small areas of
necrosis were observed.
The patient was treated using APS technology.
An MK2 US two channel machine produced by Tech
Pulse Manufacturing Pty Ltd. South Africa was used.
Four gel electrodes PALS Platinum Blue 901220, 5
¥ 5 cm, were placed on both sides of the left upper
leg and under his feet. The current intensity was
slowly increased with potentiometer until the pa-
tient could feel it under the electrodes. The current
intensity was then decreased to just below the
threshold and the therapy was continued for 8 min-
utes in one session.
He was swapped to oxycodone controlled re-
lease 30 mg bd and oxycodone immediate release
15 mg, paracetamol 1 g and ketamine 30 mg per
dose. After the first treatment the patient suffered
severe muscle shakes but was not breathless, agi-
tated or had hyperthermia. The therapy was ad-
ministered usually in the morning and this result-
ed in 6–7 hours of analgesia. At the later stage the
treatment intensity was increased to 8 minutes
therapy twice daily. This resulted in much better
analgesia, especially at night. He used his break-
through medication once or twice a day. He felt so
much better that he volunteered to undergo ra-
diotherapy again.
Ischemic pain can originate from vascular in-
traluminal obstruction, usually by thrombo-embo-
lus, external compression by the tumour and dis-
secting aneurysm. Deep venous thrombosis, like in
our case can cause ischemic pain in the situation
where the arterial circulation is already compro-
mised. Increased pressure in the limb, due to con-
gestion may especially impair circulation in new
collaterals.
Pharmacological treatment of this kind of pain
is very difficult. Fraxionated heparine (Fraxiparin) is
the treatment of choice as it has a potential of de-
creasing congestion in the limb and decreasing the
pressure [13]. However, in our case this treatment
was not effective and needed to be discontinued
because of serious haemorrhage.
Another possibility in this treatment is the use
of ketamine in combination of morphine. This
treatment is sometimes effective at the higher
doses and it is frequent that the cognitive func-
tions of the patients are severely compromised. In
our case the original treatment with morphine
alone was not effective and needed to be changed.
We have chosen for oxycodone as this drug has
less potential to compromise cognitive function-
ing [14]. Ketamine and paracetamol were added
to the “acute” break through doses and appeared
to be adequate.
Important in the treatment is positioning of the
patients. Some patients prefer to sit in the chair
with their leg supported. A good explanation for
this was found by Ubbink et al [15]. Under physio-
logical conditions arterioles respond with vasocon-
striction when changing position from supine to
sitting. This is probably due to increased sympa-
thetic tonus. However, this mechanism is probably
disturbed in patients experiencing ischemic pain and
the perfusion of the limb is higher in sitting than in
supine position.
The main treatment was by applying a new tech-
nology of APS. Action potential simulation simu-
lates the bio-currents. The sub-threshold electric
current has as an effect on the synthesis of the ATP
by the cells. In that way the cells can be “vitalised”
and damages can be repaired. This is very much
different to the use of TENS principle, where the
electric shocks stimulate nociceptors and close the
“gate” in the spinal cord hampering the convey-
ance of ascending pain impulses. However, com-
parison of the two methods reveals short term sim-
ilar results [11]. In our patient APS was effective
within several minutes after the first treatment.
Apparently the patient experienced during the first
night severe shaking without increased body tem-
perature or breathlessness. This reaction, seen very
often by the APS therapist, suggest that some tox-
ins are freed from the ischemic area and are ab-
sorbed to the circulation.
www.advpm.eu 25
Anette Spitz-Meyer, Zbigniew Zylicz, Management of ischemic pain with APS
Discussion
Treatment with APS not only improved pain but
also, visibly, improved skin circulation as within sev-
eral days the necrotic discolorations of the skin dis-
appeared. Potentially the therapy may improve col-
lateral circulation to such an extent that the patient
may discontinue it one time.
In the Netherlands and in Poland, APS therapy is
known by the physiotherapists. However, in the UK,
there is much less interest in development of these
kind of methods. Before the method can be used in
routine treatments, it should be first validated in
different clinical settings, the staff should be trained
to use it and cheap devices can be developed and
used by the patients themselves. Our case suggest
that the method may be useful in some otherwise
intractable pain conditions.
However, before we shall conduct clinical trials,
we should better understand how the technology is
working and what kind of physiological effects are
involved. Without this, clinical trials lacking this in-
ternal validity may render negative results [16] and
the technology will be discarded before it is under-
stood.
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